ISTH/LinkedIn
Aug 14, 2026, 06:26
Delivering Gene Therapy in Hemophilia – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared on LinkedIn:
“Delivering gene therapy in hemophilia isn’t just a clinical decision, it’s an operational one. From referral pathways to long-term monitoring, successful implementation requires coordination across teams, systems, and care models.
Our new resource builder helps you not only navigate referral, preparation, and administration workflows, but grants you access to tools tailored to your region and practice setting.
Support your team in managing the complexities of gene therapy by building a personalized set of implementation resources and taking the next step toward integrating gene therapy into practice!”
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments